Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 5;40(8):225.
doi: 10.1007/s12032-023-02101-x.

Impact of exosome therapy on pancreatic cancer and its progression

Affiliations
Review

Impact of exosome therapy on pancreatic cancer and its progression

Mohamed El-Tanani et al. Med Oncol. .

Abstract

Pancreatic cancer, one of the most aggressive tumors, has a dismal prognosis because of the low rates of early identification, fast progression, difficulties following surgery, and the ineffectiveness of current oncologic therapies. There are no imaging techniques or biomarkers that can accurately identify, categorize, or predict the biological behavior of this tumor. Exosomes are extracellular vesicles that play a crucial rule in the progression, metastasis, and chemoresistance of pancreatic cancer. They have been verified to be potential biomarkers for pancreatic cancer management. Studying the role of exosomes in pancreatic cancer is substantial. Exosomes are secreted by most eukaryotic cells and participated in intercellular communication. The components of exosomes, including proteins, DNA, mRNA, microRNA, long non-coding RNA, circular RNA, etc., play a crucial role in regulating tumor growth, metastasis, and angiogenesis in the process of cancer development, and can be used as a prognostic marker and/or grading basis for tumor patients. Hereby, in this concise review, we intend to summarize exosomes components and isolation, exosome secretion, function, importance of exosomes in the progression of pancreatic cancer and exosomal miRNAs as possible pancreatic cancer biomarkers. Finally, the application potential of exosomes in the treatment of pancreatic cancer, which provides theoretical supports for using exosomes to serve precise tumor treatment in the clinic, will be discussed.

Keywords: Biomarkers; Exosomes; Folfirinox; Gemcitabine; Intercellular communication; Pancreatic cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
A typical exosomes composition and structure of exosomes
Fig. 2
Fig. 2
Production and secretion of exosomes
Fig. 3
Fig. 3
Exosomes impact on pancreatic cancer progression
Fig. 4
Fig. 4
Exosomes in immunotherapy

References

    1. Qiu J, et al. Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications. Mol Cancer. 2018;17(1):2. - PMC - PubMed
    1. Kanji, Z.S. and S. Gallinger, 2013 Diagnosis and management of pancreatic cancer. CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne. 185(14): 1219–1226. - PMC - PubMed
    1. Greenwell M, Rahman PKSM. Medicinal plants: their use in anticancer treatment. Int J Pharm Sci Res. 2015;6(10):4103–4112. - PMC - PubMed
    1. Pappalardo A, et al. Adjuvant treatment in pancreatic cancer: shaping the future of the curative setting. Front Oncol. 2021 doi: 10.3389/fonc.2021.695627. - DOI - PMC - PubMed
    1. van Roessel S, et al. Evaluation of adjuvant chemotherapy in patients with resected pancreatic cancer after neoadjuvant FOLFIRINOX treatment. JAMA Oncol. 2020;6(11):1733–1740. - PMC - PubMed